Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesClinical/Medical PolicyWPS Health Neuropsych Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentWPS Health InsurancePolicy PUM 250-0006

    Neuropsychological Testing Medical Guideline

    Customize your policy alerts

    Sign up for WPS Health Insurance Policy PUM 250-0006 alerts

    Get alerted when Policy PUM 250-0006 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This guideline governs when neurobehavioral status examinations and neuropsychological testing are medically necessary, experimental, investigational, unproven, or not medically necessary. It applies to providers requesting or performing testing for members, subject to the member's benefit plan, network requirements, and applicable law.

    Policy Summary
    PayerWPS Health Insurance
    PolicyNeuropsychological Testing Medical Guideline
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionVerify the member's benefit plan for coverage, exclusions, prior-authorization requirements, and benefit limitations before requesting testing.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    >10 hoursTesting duration requiring Medical Director review
    1 yearRetesting interval without clear justification
    13Not medically necessary situations
    At least 1Qualifying condition or situation required
    07/01/2026Approval effective date

    Medical Necessity and Coverage Criteria

    Neurobehavioral Status Exam

    The neurobehavioral status exam is medically necessary for the following purposes:

    ANY of the following

    • Evaluate possible issues with cognitive functioning.
    • Determine the need for neuropsychological testing.
    • Evaluate the efficacy of treatment for a previously diagnosed cognitive issue.

    Initial Neuropsychological Testing

    Neuropsychological testing (NPT) is medically necessary to direct further medical care when ALL of the following criteria are met:

    ALL of the following

    Policy Summary
    PayerWPS Health Insurance
    PolicyNeuropsychological Testing Medical Guideline
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionVerify the member's benefit plan for coverage, exclusions, prior-authorization requirements, and benefit limitations before requesting testing.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaDuration and Retesting ParametersAuthorization, Documentation, and Denial RisksClinical ContextKey Definitions

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Documentation of a neurobehavioral status exam or thorough evaluation by a neurologist, psychiatrist, or psychologist indicates the need for NPT.
  1. At least ONE medical condition or situation is present

    • Head injury, including open or closed head injury or traumatic brain injury.
    • Stroke or cerebral vascular injury, such as brain aneurysm or subdural hematoma.
    • Brain tumor.
    • Cerebral anoxic or hypoxic episode.
    • Severe central nervous system infection.
    • Suspected autism spectrum disorder, before treatment and to evaluate or compare testing following at least one year of treatment.
    • Neoplasm or vascular injury of the central nervous system.
    • Neurodegenerative disorder, such as Lewy body dementia, primary progressive aphasia, Alzheimer's disease, or vascular dementia.
    • Demyelinating disease, such as multiple sclerosis.
    • Epilepsy or seizure disorder.
    • Extrapyramidal disease, such as Parkinson's disease or Huntington's disease.
    • Metabolic encephalopathy after disease stabilization.
    • Exposure to agents associated with neurodysfunction, such as intrathecal methotrexate, cranial irradiation, or lead poisoning; occupational hazards such as chronic solvent exposure are included when a covered benefit.
    • A psychiatric diagnosis has been ruled out or is not responsive to appropriate treatment, and testing is requested to distinguish between a psychiatric and neurologic syndrome affecting neurocognitive function.
    • Unusual, complex, or co-morbid symptoms require clarification that can only be accomplished through neuropsychological testing, such as worsening symptoms despite appropriate treatment or differentiating medication-related delirium from a progressive process.
    • Complicated attention-deficit/hyperactivity disorder (ADHD) meeting the criteria described under Complicated ADHD.
  2. The neuropsychological tests employed are likely to produce the diagnostic and treatment clarification required.
  3. At least ONE of the following conditions or situations is present

    • A significant mental status change not due to a metabolic disorder, such as a diabetic hypoglycemic episode, that has not responded to acute medical therapy.
    • A significant behavioral deficit or change, memory loss, inability to perform simple calculations or abstract tasks, organic brain injury, sensory illusions, or another serious circumscribed cognitive deficit, when comprehensive medical and psychological evaluation has been unable to establish a diagnosis.
    • Re-evaluation of an individual with decreasing cognitive function due to a neurological disorder when results are intended to guide treatment.
    • A comprehensive evaluation of a child with suspected autism spectrum disorder to assist in establishing the proper diagnosis and treatment plan.
  4. Complicated ADHD

    Testing for complicated ADHD is medically necessary only when ALL of the following criteria are met:

    ALL of the following

    • Specific neurocognitive behavioral deficits related to ADHD need to be evaluated.
      • At least ONE qualifying condition

        • Concussion or traumatic brain injury.
        • History of central nervous system infection.
        • Intractable seizure disorder.
        • Cancer treatment effects.
        • Genetic disorder.
        • Inborn error of metabolism.
        • History of stroke, hypoxic-ischemic encephalopathy, or intracranial vascular malformation.

    Post-Concussion Testing

    Non-baseline neuropsychological testing for concussion management is medically necessary when ALL of the following are met:

    ALL of the following

    • Testing is non-baseline neuropsychological testing, such as ImPACT.
    • Testing is performed by a physician, psychologist, or licensed mental health professional.
    • Testing is used for management of concussion.

    If NPT is used for a condition or diagnosis other than those listed in the Indications of Coverage, it is considered experimental, investigational, and unproven as affecting health outcomes. If the condition or diagnosis is listed but the coverage criteria are not met, the service is considered not medically necessary. Computerized or computer-based cognitive testing or neuropsychological assessment devices, such as Creyos, Cognitrax, or Neurotrax, are considered experimental, investigational, and unproven.

    Unless specified as a health plan exclusion, NPT is not medically necessary for uncomplicated attention deficit disorder with or without hyperactivity (ADD/ADHD); educational purposes, including assessment of learning style, learning disability, academic ability, development of an educational plan, or uncomplicated attention deficit disorder; obtaining or maintaining employment or improving job performance; conditions of parole or probation or judicial or legal purposes; requests from a third party such as a school or place of employment; solely documenting or monitoring treatment efficacy, including use of the Gordon Continuous Performance Test or Test of Variables of Attention; retesting within one year without clear clinical justification; baseline neuropsychological testing, including ImPACT, in asymptomatic persons; routine testing upon admission for a behavioral health condition; or testing while a member is engaged in substance misuse, is in withdrawal, or has only recently become abstinent from drugs or alcohol, when testing may be unreliable.

    Testing time varies according to the number of tests performed and the individual's cognitive and health status. More than 10 hours of testing is considered not medically necessary and requires Medical Director review.

    NPT is not medically necessary when there is no documentation of a thorough medical evaluation by a physician, including primary care, specialty care, or both, before the request; when the request is solely to confirm the working diagnosis and treatment plan; or when there is no documentation of how testing will benefit development of the treatment plan.

    Duration and Retesting Parameters

    Maximum testing duration
    Testing duration thresholdMore than 10 hours of neuropsychological testing
    Review requirementRequires Medical Director review
    Coverage statusConsidered not medically necessary
    Retesting interval
    Minimum intervalRetesting within one year
    ExceptionPermitted when there is clear clinical justification
    Without justificationRetesting within one year is not medically necessary

    Authorization, Documentation, and Denial Risks

    Prior Authorization

    Verify Plan Coverage and Authorization

    Before scheduling or submitting neuropsychological testing, verify the member’s applicable benefit plan, contract, and endorsements for coverage, exclusions, prior authorization, and benefit requirements. Confirm network and benefit details with the member’s plan or customer service; coverage varies by plan and this guideline does not guarantee payment.

    • Review plan-specific exclusions and limitations.
    • Confirm whether prior authorization or Medical Affairs/Medical Director review is required.
    • Verify benefit limits, network status, and applicable coding requirements before services are rendered.
    Documentation Required

    Required Clinical Documentation

    Submit a Standard Written Order from a qualified healthcare provider addressing the member’s diagnosis, along with medical records and documentation supporting medical necessity. The record should explain the clinical purpose of testing and how the results will inform treatment planning.

    • Referral source and the person or entity to whom results will be conveyed.
    • Tests proposed and the amount of time requested to complete the evaluation.
    • Treatment-planning issue the testing is expected to clarify.
    • Clinical summary, including differential diagnosis, prior evaluations, and therapies or remediation attempted.
    • Continued need or use, when applicable, and correct coding that meets all coding guidelines.
    Note

    Confirm Provider Eligibility

    The provider performing the testing must be a covered provider for the member’s particular illness or injury under the applicable benefit plan and condition being evaluated.

    • Confirm that the testing provider is eligible and covered for the specific condition or injury.
    • Verify provider and network status under the member’s plan before testing.
    Denial Risk

    Unlisted Condition or Diagnosis

    If neuropsychological testing is used for a condition or diagnosis other than one listed in the guideline’s Indications of Coverage, it is considered experimental, investigational, and unproven as affecting health outcomes and is not medically necessary under the clinical guidelines.

    • Match the requested testing to a covered indication before submitting the request.
    • Unlisted conditions or diagnoses may result in denial as experimental, investigational, and unproven.
    Denial Risk

    Criteria Not Met

    When the condition or diagnosis is listed in the Indications of Coverage but the applicable criteria are not met, the testing is considered not medically necessary. Document the required prior evaluation, qualifying condition or situation, diagnostic or treatment clarification, and intended treatment-planning benefit.

    • A neurobehavioral status exam or thorough evaluation by a neurologist, psychiatrist, or psychologist must indicate the need for testing when required.
    • The member must have a qualifying medical condition or situation and the testing must be likely to provide required diagnostic or treatment clarification.
    • Failure to satisfy any applicable coverage criterion can result in a not-medically-necessary determination.
    Denial Risk

    Computerized Testing Devices

    Computerized or computer-based cognitive testing and neuropsychological assessment devices are considered experimental, investigational, and unproven, and therefore are not medically necessary under the clinical guidelines.

    • Examples include Creyos, Cognitrax, and Neurotrax.
    • Do not assume coverage for a computerized device merely because neuropsychological testing is otherwise an indicated service.
    Denial Risk

    Testing Over 10 Hours

    Testing that exceeds 10 hours is considered not medically necessary and requires Medical Director review. Include the requested testing time and supporting clinical rationale in the authorization submission.

    • Document the amount of time requested to complete the evaluation.
    • Obtain Medical Director review for more than 10 hours of testing.
    Denial Risk

    Excluded or Unsupported Purposes

    Unless the situation is specifically excluded by the health plan, neuropsychological testing is not medically necessary when the request lacks required clinical support or is made for an unsupported purpose. Document a thorough medical evaluation, the expected treatment-planning benefit, and a clear clinical justification before requesting testing.

    • No documented thorough medical evaluation by a primary-care or specialty physician before the request.
    • Request is solely to confirm a working diagnosis or treatment plan, or there is no documentation that testing will benefit development of the treatment plan.
    • Uncomplicated ADD/ADHD, including testing for uncomplicated attention deficit disorder with or without hyperactivity.
    • Educational purposes, including learning style, learning disability, academic ability, educational-plan development, or similar school-related assessment.
    • Obtaining or maintaining employment or improving job performance.
    • A parole, probation, judicial, or other legal purpose; or a request from a third party such as a school or employer.
    • Solely documenting or monitoring treatment efficacy, including tests such as the Gordon Continuous Performance Test or Test of Variables of Attention for ADHD management.
    • Retesting within one year without clear clinical justification.
    • Baseline neuropsychological testing, including ImPACT, in an asymptomatic person.
    • Routine testing upon admission for a behavioral health condition.
    • Testing during active substance misuse, withdrawal, or only recently achieved abstinence from drugs or alcohol, when results may be unreliable.

    Clinical Context

    Neuropsychological testing objectively evaluates cognitive domains such as attention, memory, language, executive function, perception, problem solving, and adaptation in patients with known or suspected brain injury or abnormality. Results may support diagnosis, prognosis, treatment planning, evaluation of treatment goals, and disposition, but testing does not replace clinical interviews or medical, neurologic, or psychological examinations.

    Key Definitions

    Neuropsychological tests (NPT)
    DefinitionEvaluations designed to determine the functional consequences of known or suspected brain injury or abnormality
    MethodTesting of neurocognitive domains responsible for language, perception, memory, learning, problem solving, and adaptation
    Nature of testingNeuropsychological test batteries usually involve extensive evaluation of multiple cognitive domains
    Neurobehavioral status exam
    DefinitionA clinical evaluation used to assess cognitive functioning
    Testing determinationUsed to determine the need for neuropsychological testing
    Treatment evaluationUsed to evaluate treatment efficacy for a previously diagnosed cognitive issue